{
    "URL": "https://doi.org/10.1371/journal.pntd.0006504",
    "Published": "June 13, 2018",
    "Subject_Areas": [
        "African trypanosomiasis",
        "Trypanosoma",
        "Cerebrospinal fluid",
        "Drug therapy",
        "Medical risk factors",
        "Death rates",
        "Parasitic diseases",
        "Adverse events"
    ],
    "Authors": {
        "L\u00e9on Mbiyangandu Kazumba": [
            "D\u00e9partment de Neurologie, Universit\u00e9 de Kinshasa, Kinshasa, R\u00e9publique D\u00e9mocratique du Congo (RDC)"
        ],
        "Jean-Claude Tshinzobe Kaka": [
            "Institut Sup\u00e9rieur de Techniques M\u00e9dicales, Kinshasa, D\u00e9mocratique du Congo (RDC)"
        ],
        "Dieudonn\u00e9 Mumba Ngoyi": [
            "D\u00e9partment de M\u00e9decine Tropicale, Universit\u00e9 de Kinshasa, Kinshasa, D\u00e9mocratique du Congo (RDC)",
            "Institut National de Recherches Biom\u00e9dicales (INRB), Kinshasa, D\u00e9mocratique du Congo (RDC)"
        ],
        "D\u00e9sir\u00e9 Tshala-Katumbay": [
            "D\u00e9partment de Neurologie, Universit\u00e9 de Kinshasa, Kinshasa, R\u00e9publique D\u00e9mocratique du Congo (RDC)",
            "Institut National de Recherches Biom\u00e9dicales (INRB), Kinshasa, D\u00e9mocratique du Congo (RDC)",
            "D\u00e9partment of Neurology and School of Public Health, Oregon Health & Science University, Portland, OR, United States of America"
        ]
    }
}